140 related articles for article (PubMed ID: 15913560)
1. Ligand binding to the human MT2 melatonin receptor: the role of residues in transmembrane domains 3, 6, and 7.
Mazna P; Berka K; Jelinkova I; Balik A; Svoboda P; Obsilova V; Obsil T; Teisinger J
Biochem Biophys Res Commun; 2005 Jul; 332(3):726-34. PubMed ID: 15913560
[TBL] [Abstract][Full Text] [Related]
2. Molecular modeling of human MT2 melatonin receptor: the role of Val204, Leu272 and Tyr298 in ligand binding.
Mazna P; Obsilova V; Jelinkova I; Balik A; Berka K; Sovova Z; Ettrich R; Svoboda P; Obsil T; Teisinger J
J Neurochem; 2004 Nov; 91(4):836-42. PubMed ID: 15525337
[TBL] [Abstract][Full Text] [Related]
3. The role of proline residues in the structure and function of human MT2 melatonin receptor.
Mazna P; Grycova L; Balik A; Zemkova H; Friedlova E; Obsilova V; Obsil T; Teisinger J
J Pineal Res; 2008 Nov; 45(4):361-72. PubMed ID: 18544139
[TBL] [Abstract][Full Text] [Related]
4. Molecular cloning and pharmacological characterization of rat melatonin MT1 and MT2 receptors.
Audinot V; Bonnaud A; Grandcolas L; Rodriguez M; Nagel N; Galizzi JP; Balik A; Messager S; Hazlerigg DG; Barrett P; Delagrange P; Boutin JA
Biochem Pharmacol; 2008 May; 75(10):2007-19. PubMed ID: 18384758
[TBL] [Abstract][Full Text] [Related]
5. Analysis of structure-activity relationships for MT2 selective antagonists by melatonin MT1 and MT2 receptor models.
Rivara S; Lorenzi S; Mor M; Plazzi PV; Spadoni G; Bedini A; Tarzia G
J Med Chem; 2005 Jun; 48(12):4049-60. PubMed ID: 15943478
[TBL] [Abstract][Full Text] [Related]
6. Identification of ligand binding residues in extracellular loops of the melanocortin 1 receptor.
Chhajlani V; Xu X; Blauw J; Sudarshi S
Biochem Biophys Res Commun; 1996 Feb; 219(2):521-5. PubMed ID: 8605020
[TBL] [Abstract][Full Text] [Related]
7. High-throughput screening assay for new ligands at human melatonin receptors.
Yan JH; Su HR; Boutin JA; Renard MP; Wang MW
Acta Pharmacol Sin; 2008 Dec; 29(12):1515-21. PubMed ID: 19026172
[TBL] [Abstract][Full Text] [Related]
8. The functional role of cysteines adjacent to the NRY motif of the human MT1 melatonin receptor.
Kokkola T; Salo OM; Poso A; Laitinen JT
J Pineal Res; 2005 Aug; 39(1):1-11. PubMed ID: 15978051
[TBL] [Abstract][Full Text] [Related]
9. Tricyclic alkylamides as melatonin receptor ligands with antagonist or inverse agonist activity.
Lucini V; Pannacci M; Scaglione F; Fraschini F; Rivara S; Mor M; Bordi F; Plazzi PV; Spadoni G; Bedini A; Piersanti G; Diamantini G; Tarzia G
J Med Chem; 2004 Aug; 47(17):4202-12. PubMed ID: 15293992
[TBL] [Abstract][Full Text] [Related]
10. The predicted 3D structures of the human M1 muscarinic acetylcholine receptor with agonist or antagonist bound.
Peng JY; Vaidehi N; Hall SE; Goddard WA
ChemMedChem; 2006 Aug; 1(8):878-90. PubMed ID: 16902941
[TBL] [Abstract][Full Text] [Related]
11. Homology modeling of MT1 and MT2 receptors.
Farce A; Chugunov AO; Logé C; Sabaouni A; Yous S; Dilly S; Renault N; Vergoten G; Efremov RG; Lesieur D; Chavatte P
Eur J Med Chem; 2008 Sep; 43(9):1926-44. PubMed ID: 18255198
[TBL] [Abstract][Full Text] [Related]
12. Preferential formation of MT1/MT2 melatonin receptor heterodimers with distinct ligand interaction properties compared with MT2 homodimers.
Ayoub MA; Levoye A; Delagrange P; Jockers R
Mol Pharmacol; 2004 Aug; 66(2):312-21. PubMed ID: 15266022
[TBL] [Abstract][Full Text] [Related]
13. Molecular cloning and pharmacological characterization of monkey MT1 and MT2 melatonin receptors showing high affinity for the agonist ramelteon.
Nishiyama K; Shintani Y; Hirai K; Yoshikubo S
J Pharmacol Exp Ther; 2009 Sep; 330(3):855-63. PubMed ID: 19556449
[TBL] [Abstract][Full Text] [Related]
14. Homology models of melatonin receptors: challenges and recent advances.
Pala D; Lodola A; Bedini A; Spadoni G; Rivara S
Int J Mol Sci; 2013 Apr; 14(4):8093-121. PubMed ID: 23584026
[TBL] [Abstract][Full Text] [Related]
15. Refinement of a homology model of the mu-opioid receptor using distance constraints from intrinsic and engineered zinc-binding sites.
Fowler CB; Pogozheva ID; LeVine H; Mosberg HI
Biochemistry; 2004 Jul; 43(27):8700-10. PubMed ID: 15236578
[TBL] [Abstract][Full Text] [Related]
16. Design and synthesis of 3-phenyltetrahydronaphthalenic derivatives as new selective MT2 melatoninergic ligands. Part II.
Durieux S; Chanu A; Bochu C; Audinot V; Coumailleau S; Boutin JA; Delagrange P; Caignard DH; Bennejean C; Renard P; Lesieur D; Berthelot P; Yous S
Bioorg Med Chem; 2009 Apr; 17(8):2963-74. PubMed ID: 19329323
[TBL] [Abstract][Full Text] [Related]
17. Bicyclic melatonin receptor agonists containing a ring-junction nitrogen: Synthesis, biological evaluation, and molecular modeling of the putative bioactive conformation.
Elsner J; Boeckler F; Davidson K; Sugden D; Gmeiner P
Bioorg Med Chem; 2006 Mar; 14(6):1949-58. PubMed ID: 16290939
[TBL] [Abstract][Full Text] [Related]
18. Structure-based virtual screening of MT2 melatonin receptor: influence of template choice and structural refinement.
Pala D; Beuming T; Sherman W; Lodola A; Rivara S; Mor M
J Chem Inf Model; 2013 Apr; 53(4):821-35. PubMed ID: 23541165
[TBL] [Abstract][Full Text] [Related]
19. Temperature-dependent variations of ligand-receptor contact points in hAT(1).
Arsenault J; Renaud MP; Clément M; Fillion D; Guillemette G; Leduc R; Lavigne P; Escher E
J Pept Sci; 2007 Sep; 13(9):575-80. PubMed ID: 17600857
[TBL] [Abstract][Full Text] [Related]
20. XFEL structures of the human MT
Johansson LC; Stauch B; McCorvy JD; Han GW; Patel N; Huang XP; Batyuk A; Gati C; Slocum ST; Li C; Grandner JM; Hao S; Olsen RHJ; Tribo AR; Zaare S; Zhu L; Zatsepin NA; Weierstall U; Yous S; Stevens RC; Liu W; Roth BL; Katritch V; Cherezov V
Nature; 2019 May; 569(7755):289-292. PubMed ID: 31019305
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
